SARAH FLEMING: Open Payments
NPI 1629586102 · WEST PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,373 in 105 payments from 38 companies in 2025. Trend: 2023 $1,610 · 2024 $1,563 · 2025 $2,373
Food & beverage: $2,373
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $375 |
| ABBVIE INC. | 10 | $184 |
| Genentech USA, Inc. | 2 | $171 |
| Novartis Pharmaceuticals Corporation | 11 | $156 |
| Stemline Therapeutics Inc. | 4 | $104 |
| Legend Biotech USA Inc. | 4 | $96 |
| GENZYME CORPORATION | 4 | $90 |
| Incyte Corporation | 3 | $80 |
| Daiichi Sankyo Inc. | 3 | $77 |
| SOBI, INC | 2 | $72 |
Products named: CARVYKTI, Ocrevus, TECVAYLI, Orserdu, ELAHERE, RYBREVANT, Enhertu, EPKINLY.
Industry payments across FL — which companies pay providers there.
